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will be evaluated for both general
behavior and for learning capability
while they are maturing. As adults,
they will undergo a series of com-
plex learning/relearning trials to
probe for subtle changes in inte-
grated brain function. Reproduc-
tive toxicity will be evaluated using
a number ofindices ofsexual devel-
opment and puberty and, in adult
animals, a thorough assessment of
reproductive function and struc-
ture. Exposed animals will be
paired with untreated mates to
identify which gender is affected.
Hormone and ovulation studies
may be conducted if there is evi-
dence that ovulation was impaired
in the exposed females. A subset of
animals in immunotoxicity studies
will be exposed to evaluate their
immune responses in vivo, while
others will provide tissues for in
vitro evaluation ofvarious immune
cellular functions.
Study chemicals were chosen to
represent a variety ofstructures and
classes of pesticides. In the first
study, methoxychlor will be used as
a positive control based on data
from Earl Gray and colleagues at
EPA. They have shown that meth-
oxychlor has significant reproduc-
tive effects in animals exposed as
juveniles. Tebuconazole is repre-
sentative of a widely used class of
antifungal compounds that exhibit
reproductive and developmental toxicities.
The organophosphates are represented by
chlorpyrifos, a relatively long-acting
organophosphate, and parathion, a rela-
tively short-acting organophosphate.
Carbaryl will represent the carbamates,
another neuroactive class that may have
reproductive effects. Atrazine will be evalu-
ated based on its heavy use in the United
States, its prevalence in groundwater sup-
plies, and its reported reproductive activi-
ty. Finally, trichlorfon, another organo-
phosphate, is included because it has been
reported to be associated with adverse
reproductive outcomes in
humans.
Because the organophos-
phates and carbaryl alter neu-
rochemical enzymes in known
ways, the degree of these
effects will be monitored in
animals sacrificed both during
and after exposure. Acetyl-
cholinesterase inhibition will
be evaluated at EPA and also
by Mohammed Abou-Donia
at Duke University. This will
allow a correlation between a
known amount of enzyme
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Testing timeline. NIEHS researchers are designing a studyto look at
the effects of pesticide exposure on the nervous, immune, and repro-
ductive systems ofjuveniles.
inhibition and subsequent behavioral and
cognitive function.
By comparing the effects and effective
doses in these young animals with those
from adults, researchers will be able to tell
ifthere are significant differences between
these age groups and will have some
appreciation for the degree of the prob-
lem, if one exists. If the data suggest that
the health risks from juvenile exposures to
pesticides has been underestimated, these
studies will be the first step in a larger
evaluation ofthe problem.
Frontiersman of
Science
Stanley Cohen, who shared
the Nobel Prize in 1986 in
physiology and medicine for
his pioneering discoveries of
growth factors, was the key-
note speaker at the April
"Frontiers of Science Mini-
Symposium" sponsored by
NIEHS. Cohen's symposium
was titled "Growth Factors
and Related Signaling Path-
ways." At the symposium,
presentations outlining recent, excit-
ing findings were given by prominent
scientists from UNC-Chapel Hill,
Duke University, Glaxo Research
Institute, and NIEHS.
Growth factors are small proteins
that are produced by nearly all tissues
and provide potent, local signals that
affect behavior ofnearby cells or even
cells that produce the factor. The var-
ious cellular activities regulated by
growth factors are extensive and
include such events as cell growth
and maturation, cell repair, and
transport of ions. Specific receptors
at the surface of cells determine
whether a cell will recognize a partic-
ular growth factor.
In his keynote address, Cohen
detailed the large body ofhis research,
giving a context for the symposium's
other presentations. He reviewed his
pioneering Nobel Prize-winning work
of30 years ago on the purification of
epidermal growth factor (EGF). His
subsequent work has led to the char-
acterization of the response of cells
and organisms to EGF stimulation,
while his recent work has focused on
the specific biochemical changes
induced by EGF binding to its recep-
tor in the cell membrane. This bind-
ing activates the receptor's enzymatic
activity, leading to its interaction with
other cellular proteins which lead to
metabolic changes in the EGF-stimu-
lated cell.
Since Cohen's pioneering work in
growth factor research, hundreds ofgrowth
factors have been discovered. The function
ofmany ofthese factors, however, remains
elusive. Many researchers are currently
attempting to learn more about the large
number ofbiochemical changes that occur
in cells following interaction ofgrowth fac-
tors with complementary receptors.
Understanding these regulatory circuits in
cells might provide insight into the origins
ofsome diseases. Cancer cells, for instance,
exhibit changes at nearly every level of
some growth factor pathways and many
investigations are currently attempting to
link specific changes in these pathways
with the capacity of cells to change into
cancer cells.
Goldstein on Risk
Assessment
Bernard D. Goldstein spoke at the Risk
Assessment Research Seminar Series on
April 22 at NIEHS on comparative risk
assessment. Goldstein is the director ofthe
Environmental and Occupational Health
Sciences Institute and chair of the
Department of Environmental and
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